Recombinant Equine Ifnb1

• Cat.No.: Ifnb1-101E
• Product Overview: Equine IFN beta 1 was produced in yeast and therefore does not have endotoxin, is naturally folded, and post-translationally modified.

Specification

• Species: Equine
• Source: Yeast
• Tag: Non
• Description: Type I interferons (IFN alpha, IFN beta) belong to the helical cytokine superfamily, which includes growth hormones, interleukins, several colony-stimulating factors plus other regulatory molecules. All function as regulators of cellular activity by interacting with cell-surface receptors and activating various signaling pathways. IFN beta produces antiviral, antibacterial, and anticancer properties. RANKL (TNFSF11) has been shown to induce the production of IFN beta.
• Form: Lyophilized without carrier protein.
• Molecular Mass: Equine IFN beta 1 has a predicted molecular weight of 19.5 kDa.
• AA Sequence: SYDVLRYQQR SSNLACQKLL GQLPGTPQYC LEDRMNFEVP EEIMQPPQFQ KEDAVLIIHE MLQQIFGILR RNFSSTGWNE TVIKTILVEL DGQMDDLETI LEEIMEEENF PRGDMTILHL KKYYLSILQY LKSKEYRSCA WTVVQVEILR NFSFLNRLTD YLRN
• Purity: >95% as visualized by SDS-PAGE analysis.
• Applications: The IFN beta protein can be used in cell culture, as a IFN beta ELISA Standard, and as a Western Blot Control.
• Storage: Stable for up to twelve months from date of receipt at -20?C. Stable for at least 3 months when stored in working aliquots with a carrier protein at -20?C. Avoid repeated freeze/thaw cycles.
• Reconstitution: Reconstitute with sterile phosphate-buffered saline containing at least 0.1% carrier protein.